Advertisement
In 2015 to 2018

CDC: 10.7 Percent of U.S. Adults Used Rx Pain Meds in 2015 to 2018

0
No change found in use of prescription opioids from 2009-2010 to 2017-2018, but increase seen in nonopioid meds
Johnson & Johnson and a subsidiary must pay $2.1 billion in damages to women who said their ovarian cancers were caused by the company's baby powder and other talcum products

J&J Ordered to Pay $2.1 Billion in Talcum Product Lawsuit

0
Decision reduced by more than half the record award of $4.7 billion made to the women in July 2018
French drugmaker Sanofi has shortened its timeline to get a COVID-19 vaccine on the market.

Sanofi Speeds COVID-19 Vaccine Efforts

0
Company says it may be able to get a vaccine approved by regulators as early as the first half of 2021
For patients with rheumatic disease with COVID-19

COVID-19 Hospitalization Up With Prednisone in Rheumatic Disease

0
No correlation seen for DMARD alone or in combination with biologics, Janus Kinase inhibitors, NSAIDs
The occurrence of nephrogenic systemic fibrosis appears to be rare after exposure to newer gadolinium-based contrast agents

Nephrogenic Systemic Fibrosis Rare With Newer GBCA Exposure

0
Data scant on exposure to gadolinium-based contrast agents for those with acute kidney injury, risk for CKD
There is a small increased risk for subdeltoid bursitis after influenza vaccination

Small Increase Seen in Risk for Subdeltoid Bursitis With Flu Shot

0
Attributable risk was 7.78 additional cases of subdeltoid bursitis per million persons vaccinated
There could be a COVID-19 vaccine by the end of this year or early next year

COVID-19 Vaccine May Be Available by Late 2020, Early 2021: Fauci

0
Fauci cautiously optimistic about a vaccine being available in 2020-2021 time frame
African-Americans are underrepresented in clinical trials leading to approval of cancer medications

African-American Participation Inadequate in Cancer Drug Trials

0
Consistent underrepresentation seen in clinical trials evaluating medications across major cancer types
For patients with melanoma treated with immune checkpoint inhibitors (ICIs)

Vitamin D May Cut Colitis Risk for Immune Checkpoint Inhibitors

0
Odds of developing ICI colitis significantly reduced with vitamin D use in patients with melanoma
For patients with chronic low back pain

Tanezumab Improves Pain, Function in Chronic Low Back Pain

0
Low back pain intensity at week 16 was improved with tanezumab 10 mg versus placebo